Effectively screen for up to 17 respiratory pathogens in a single test.
The BioCode® Respiratory Pathogen Panel* (RPP) is an FDA 510(k) cleared qualitative multiplexed nucleic acid-based in vitro diagnostic test that is capable of the simultaneous detection and identification of nucleic acids from multiple viruses and bacteria extracted from nasopharyngeal swab (NPS) samples obtained from individuals with signs and/or symptoms of an upper respiratory infection.
* The BioCode® Respiratory pathogen Panel is FDA 510(k) cleared. This product is for clinical and research applications, not individual use.
